PEDIATRICS Vol. 88 No. 3 September 1991, pp. 659-660
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BAKER, G. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BAKER, G. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In Reply: Ricelyte Advertising

G. L. BAKER MD1

1 Vice President Medical Director, Mead Johnson Nutritional Group, Mead Johnson Research Center, Evansville, Indiana 47721-0001

When any new product is introduced to the market it is extremely important to evaluate all the experimental evidence needed to support the claims. In this regard, we take strong exception to the comments of Dr J. Tulloch who is concerned that a recent advertisement run in Pediatrics for Mead Johnson's newly introduced product, Ricelyte, is misleading. After more than 4 years of research and development, stimulated in part by the extensive efforts of the World Health Organization Diarrhoeal Disease Control Programs (CDD), the Mead Johnson Research Center successfully produced from rice flour, a refined, highly specific glucose polysaccharide, "rice syrup solids."


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?